Multisite Evaluation of the BD Max Extended Enteric Bacterial Panel for Detection of Yersinia enterocolitica, Enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from Stool Specimens

The purpose of this study was to perform a multisite evaluation to establish the performance characteristics of the BD Max extended enteric bacterial panel (xEBP) assay directly from unpreserved or Cary-Blair-preserved stool specimens for the detection of , enterotoxigenic (ETEC), , and The study in...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical microbiology Vol. 55; no. 11; pp. 3258 - 3266
Main Authors Simner, Patricia J, Oethinger, Margret, Stellrecht, Kathleen A, Pillai, Dylan R, Yogev, Ram, Leblond, Helene, Mortensen, Joel
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of this study was to perform a multisite evaluation to establish the performance characteristics of the BD Max extended enteric bacterial panel (xEBP) assay directly from unpreserved or Cary-Blair-preserved stool specimens for the detection of , enterotoxigenic (ETEC), , and The study included prospective, retrospective, and prepared contrived specimens from 6 clinical sites. BD Max xEBP results were compared to the reference method, which included standard culture techniques coupled with alternate PCR and sequencing, except for ETEC, for which the reference method was two alternate PCRs and sequencing. Alternate PCR was also used to confirm the historical results for the retrospective specimens and for discrepant result analysis. A total of 2,410 unformed, deidentified stool specimens were collected. The prevalence in the prospective samples as defined by the reference method was 1.2% ETEC, 0.1% , 0% , and 0% Compared to the reference method, the positive percent agreement (PPA) (95% confidence interval [CI]), negative percent agreement (NPA) (95% CI), and kappa coefficient (95% CI) for the BD Max xEBP assay for all specimens combined were as follows: ETEC, 97.6% (87.4 to 99.6), 99.8% (99.5 to 99.9), and 0.93 (0.87 to 0.99); , 100% (96.4 to 100), 99.7% (99.4 to 99.8), and 0.96 (0.93 to 0.99); , 99.0% (94.8 to 99.8), 99.9% (99.8 to 99.9), and 0.99 (0.98 to 1); , 100% (96.4 to 100), 99.8% (99.5 to 99.9), and 0.98 (0.95 to 1), respectively. In this multicenter study, the BD Max xEBP showed a high correlation (kappa, 0.97; 95% CI, 0.95 to 0.98) with the conventional methods for the detection of ETEC, , , and in stool specimens from patients suspected of acute gastroenteritis, enteritis, or colitis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Citation Simner PJ, Oethinger M, Stellrecht KA, Pillai DR, Yogev R, Leblond H, Mortensen J. 2017. Multisite evaluation of the BD Max extended enteric bacterial panel for detection of Yersinia enterocolitica, enterotoxigenic Escherichia coli, Vibrio, and Plesiomonas shigelloides from stool specimens. J Clin Microbiol 55:3258–3266. https://doi.org/10.1128/JCM.00911-17.
ISSN:0095-1137
1098-660X
DOI:10.1128/JCM.00911-17